EFMC-ASMC'19

EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry

 Athens, Greece    September 1-5, 2019

Programme


09:00

Excursions - Tour 1

14:00

Excursions - Tour 2

14:00

Registration

17:00

Opening Lecture
T01 - The Art and Science of Total Synthesis and Its Impact on Biology and Medicine: From the Fundamentals to the Translational

Prof. K.C. NICOLAOU
RICE UNIVERSITY, Houston, United States

18:30

Welcome reception

08:30

T02 - Nature’s Medicine Chest: Opportunities for Synthesis and Drug Discovery

Prof. Margaret Anne BRIMBLE
THE UNIVERSITY OF AUCKLAND, Auckland, New Zealand

09:15

T03 - Drug Discovery in Academia

Prof. Oliver PLETTENBURG
LEIBNIZ UNIVERSITY HANNOVER, Hannover, Germany

10:00

OC01 - to be selected from the submitted abstracts

10:15

Coffee break and Exhibition

10:45

T04 - Discovery of First in Class, Orally Bioavailable p300/CBP HAT Domain Inhibitors

Dr Michael MICHAELIDES
ABBVIE, North Chicago, United States

11:30

T05 - Novel Bacterial Topoisomerase Inhibitors (NBTI) with Potent Gram-Negative Activity

Dr Cornelia ZUMBRUNN
IDORSIA PHARMACEUTICALS, Allschwil, Switzerland

12:15

OC02 - to be selected from the submitted abstracts

12:30

Lunch and Exhibition

14:00

T06 - Catalytic Chirality Generation: New Strategies for Organic Synthesis

Prof. John BOWER
UNIVERSITY OF BRISTOL, Bristol, United Kingdom

14:45

T07 - Synthesis of Versatile Intermediates Through Copper Catalysis

Prof. Mariola TORTOSA
AUTONOMOUS UNIVERSITY OF MADRID, Madrid, Spain

15:30

OC03 - to be selected from the submitted abstracts

15:45

Coffee break and Exhibition

16:15

OC04 - EFMC Prize Winner EFMC-YMCS 2016

16:30

T08 - Photoinduced Assembly of C–N Bonds

Dr Daniele LEONORI
UNIVERSITY OF MANCHESTER, Manchester, United Kingdom

17:15

T09 - Practical Heteroatom- and Group-Transfer Reactions

Dr Laszlo KURTI
RICE UNIVERSITY, Houston, United States

18:00

Closing of the day

08:30

T10 - Design and Synthesis of Chemical Probes for Bromodomains

Prof. Stuart CONWAY
UNIVERSITY OF OXFORD, Oxford, United Kingdom

09:15

T11 - Title to be announced

Dr Kim HUARD
GENENTECH, San Francisco, United States

10:00

OC05 - to be selected from the submitted abstracts

10:15

Coffee break and Exhibition

10:45

T12 - A Chemical Approach to Map Protein Interactions at the Cell Surface

Dr Erik HETT
MERCK EXPLORATORY SCIENCE CENTER, Boston, United States

11:30

T13 - From Fragments to Antibody Drug Conjugates in Emerging Oncology Targeted Therapies

Dr Laurent SCHIO
SANOFI, Vitry sur Seine, France

12:15

OC06 - to be selected from the submitted abstracts

12:30

Lunch and Exhibition

13:30

Poster session

14:30

T14 - Awareness of PAINS (Pan Assay Interference Compounds) can Accelerate the Drug Discovery Process

Prof. Jonathan BAELL
MONASH UNIVERSITY, Parkville, Australia

15:15

T15 - Artificial Intelligence in ADMET Modeling and Compound Profiling

Dr Karl-Heinz BARINGHAUS
SANOFI, Frankfurt, Germany

16:00

OC07 - to be selected from the submitted abstracts

16:15

Coffee break and Exhibition

16:45

T16 - Sustainable by Design Anti-Trypanosomatid Small Molecules: an Aspirational Goal for Medicinal Chemistry

Prof. Maria Laura BOLOGNESI
UNIVERSITY OF BOLOGNA, Bologna, Italy

17:30

T17 - Artificial Intelligence in de Novo Molecular Design

Dr Ola ENGKVIST
ASTRAZENECA, Mölndal, Sweden

18:15

Closing of the day

08:30

T18 - Amides and Chemical Education as Vehicles for Innovation

Prof. Neil GARG
UNIVERSITY OF CALIFORNIA, Los Angeles, United States

09:15

T19 - Discovery of AZD5718, a Novel 5-lipoxygenase Activating Protein (FLAP) Inhibitor

Dr Malin LEMURELL
ASTRAZENECA, Mölndal, Sweden

10:00

OC08 - to be selected from the submitted abstracts

10:15

Coffee break and Exhibition

10:45

T20 - Design and Implementation of de Novo Biosynthetic Cascades

Prof. Sabine FLITSCH
UNIVERSITY OF MANCHESTER, Manchester, United Kingdom

11:30

T21 - Catalysis for Total Synthesis

Prof. Alois FÜRSTNER
MAX PLANCK INSTITUT FUR KOHLENFORSCHUNG, Muelheim an der Ruhr, Germany

12:15

OC09 - to be selected from the submitted abstracts

12:30

Lunch and Exhibition

13:30

Poster session

14:30

T22 - Development and Application in Flow of Sustainable Synthetic Methodologies that Use Singlet Oxygen as Green Oxidant and Cascade Reaction Facilitator

Prof. Georgios VASSILIKOGIANNAKIS
UNIVERSITY OF CRETE, Heraklion, Greece

15:15

OC10 - EFMC Prize for a Young Medicinal Chemist in Academia

15:30

OC11 - EFMC Prize for a Young Medicinal Chemist in Industry

15:45

Coffee break and Exhibition

16:15

T23 - Flow Chemistry and photochemistry as a Tool for Drug Discovery

Dr Jesus ALCAZAR
J&J PHARMACEUTICAL RESEARCH AND DEVELOPMENT, Toledo, Spain

17:00

Closing of the day

20:00

Banquet

08:30

T24 - You Get What You Start With - Next Generation EGFR TKIs

Dr Harald ENGELHARDT
BOEHRINGER-INGELHEIM, Vienna, Austria

09:15

T25 - RNA Therapeutics: New Chemical Modalities Becoming a Therapeutic Reality

Dr Konrad BLEICHER
F.HOFFMANN-LA ROCHE LTD, Basel, Switzerland

10:00

OC12 - to be selected from the submitted abstracts

10:15

Coffee break and Exhibition

10:45

T26 - TLR7/8 Antagonists: from Screening to in vivo Potency

Dr Claudia BETSCHART
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland

11:30

T27 - Allosteric Activation of a Master Metabolic Regulator AMPK: Drug Discovery Opportunities and Challenges

Dr Kimberly CAMERON
PFIZER, Cambridge, United States

12:15

Closing remarks

12:30

End of the Symposium